Clinical Trial Update: Breast Cancer 2-PREVENT Translational Center of Excellence (TCE) - Metastatic Markers of Recurrent Tumor Phenotype for Breast Cancer

View source ↗

Summary

Active-not-recruiting breast cancer trial investigating metastatic markers of recurrent tumor phenotype conducted under the 2-PREVENT Translational Center of Ex…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Abramson Cancer Center at Penn Medicine | Conditions: Women With Suspected or Confirmed Recurrent Breast Cancer | Status: ACTIVE_NOT_RECRUITING